Mukul Agrawal bought 14,00,000 shares of small-cap multibagger pharmaceutical stock; FIIs also increased their holding in this stock!

Additionally, Foreign Institutional Investors/Foreign Portfolio Investors (FII/FPI) increased their holdings from 17.25 per cent to 19.45 per cent in the December quarter.

The NSE benchmark Nifty 50 index opened higher on Saturday, reaching a high of 21,720.3. However, as the day progressed, it slowly and steadily drifted lower, eventually ending approximately 150 points down from the day’s high, marking a decrease of 0.23 percent for the day. Meanwhile, the broader market indices outperformed the frontline indices, with Nifty Mid-Cap and Small-Cap ending higher by 0.68 and 0.51 per cent, respectively.

Intriguingly, a renowned investor known for his small-cap picks surfaced with an investment in a small-cap pharmaceutical stock. The stock in question is Strides Pharma Science Ltd, which has surged nearly 107 per cent in the last year, transforming into a multibagger stock for investors.

The ace investor, Mukul Mahavir Agrawal, made an appearance in the December shareholding report, holding 1.52 per cent of the company's shares, equivalent to 14,00,000 shares. Additionally, Foreign Institutional Investors/Foreign Portfolio Investors (FII/FPI) increased their holdings from 17.25 per cent to 19.45 per cent in the December quarter.

Strides Pharma Science is a pharmaceutical company specializing in the development, manufacturing, and export of a wide range of pharmaceutical products. The company has pursued both organic and inorganic growth strategies over the years, leading to its expansion into new markets and the addition of new businesses, therapy segments, and manufacturing infrastructure.

Disclaimer: The article is for informational purposes only and not investment advice.